FDA Warning Letter — Sangleaf Pharm., Co Ltd
The FDA took a Warning Letter action against Sangleaf Pharm., Co Ltd on Aug 3, 2023 (Seongnam, South Korea). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- Sangleaf Pharm., Co Ltd
- Date
- Aug 3, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Seongnam (South Korea)